453 related articles for article (PubMed ID: 16951202)
1. Organic cation transporters are determinants of oxaliplatin cytotoxicity.
Zhang S; Lovejoy KS; Shima JE; Lagpacan LL; Shu Y; Lapuk A; Chen Y; Komori T; Gray JW; Chen X; Lippard SJ; Giacomini KM
Cancer Res; 2006 Sep; 66(17):8847-57. PubMed ID: 16951202
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport.
Ludwig T; Riethmüller C; Gekle M; Schwerdt G; Oberleithner H
Kidney Int; 2004 Jul; 66(1):196-202. PubMed ID: 15200426
[TBL] [Abstract][Full Text] [Related]
4. Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
Burger H; Zoumaro-Djayoon A; Boersma AW; Helleman J; Berns EM; Mathijssen RH; Loos WJ; Wiemer EA
Br J Pharmacol; 2010 Feb; 159(4):898-908. PubMed ID: 20067471
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
7. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
[TBL] [Abstract][Full Text] [Related]
8. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.
Yokoo S; Masuda S; Yonezawa A; Terada T; Katsura T; Inui K
Drug Metab Dispos; 2008 Nov; 36(11):2299-306. PubMed ID: 18710896
[TBL] [Abstract][Full Text] [Related]
9. Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.
Yonezawa A; Inui K
Biochem Pharmacol; 2011 Mar; 81(5):563-8. PubMed ID: 21144842
[TBL] [Abstract][Full Text] [Related]
10. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.
Yokoo S; Yonezawa A; Masuda S; Fukatsu A; Katsura T; Inui K
Biochem Pharmacol; 2007 Aug; 74(3):477-87. PubMed ID: 17582384
[TBL] [Abstract][Full Text] [Related]
11. [Platinum agent-induced nephrotoxicity via organic cation transport system].
Yonezawa A
Yakugaku Zasshi; 2012; 132(11):1281-5. PubMed ID: 23123720
[TBL] [Abstract][Full Text] [Related]
12. New imidazole-coordinated chemotherapeutics with low epithelial toxicity.
Ludwig T; Fakih S; Bertram H; Krebs B; Oberleithner H
Cell Biochem Biophys; 2006; 45(1):31-41. PubMed ID: 16679562
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.
Sprowl JA; Ciarimboli G; Lancaster CS; Giovinazzo H; Gibson AA; Du G; Janke LJ; Cavaletti G; Shields AF; Sparreboom A
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11199-204. PubMed ID: 23776246
[TBL] [Abstract][Full Text] [Related]
14. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research.
Vekris A; Meynard D; Haaz MC; Bayssas M; Bonnet J; Robert J
Cancer Res; 2004 Jan; 64(1):356-62. PubMed ID: 14729645
[TBL] [Abstract][Full Text] [Related]
16. Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue.
More SS; Li S; Yee SW; Chen L; Xu Z; Jablons DM; Giacomini KM
Mol Cancer Ther; 2010 Apr; 9(4):1058-69. PubMed ID: 20371711
[TBL] [Abstract][Full Text] [Related]
17. Effect of ABCG2 on cytotoxicity of platinum drugs: interference of EGFP.
Ceckova M; Vackova Z; Radilova H; Libra A; Buncek M; Staud F
Toxicol In Vitro; 2008 Dec; 22(8):1846-52. PubMed ID: 18801423
[TBL] [Abstract][Full Text] [Related]
18. Drug transporters of platinum-based anticancer agents and their clinical significance.
Burger H; Loos WJ; Eechoute K; Verweij J; Mathijssen RH; Wiemer EA
Drug Resist Updat; 2011 Feb; 14(1):22-34. PubMed ID: 21251871
[TBL] [Abstract][Full Text] [Related]
19. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
Ekblad L; Kjellström J; Johnsson A
Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208
[TBL] [Abstract][Full Text] [Related]
20. Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.
Kunii E; Oguri T; Kasai D; Ozasa H; Uemura T; Takakuwa O; Ohkubo H; Takemura M; Maeno K; Niimi A
Cancer Chemother Pharmacol; 2015 May; 75(5):985-91. PubMed ID: 25772757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
